US$ 28.84
semaglutide patent expiry Generic INN entry, drug and freedom to operate Within weeks of the semaglutide
Description
The Ozempic pen is a prefilled prescription that is injected subcutaneously (under the skin) into your abdomen, thigh, or upper arm on a weekly basis
An oral form was recently approved in 2019 as a non-injection alternative for glycemic control [4]

A systematic review executed on animal and human studies alongside case studies (93) demonstrated a dearth of human evidence on the excretion of GLP-1 agonists in breast milk, even though GLP-1 agonists, being large peptides, could be precisely present in human milk, although the exact amount is unclear (89)

But thats not in line with the data

The drug's mechanism makes it particularly effective for people struggling with both appetite control and metabolic regulation